198 related articles for article (PubMed ID: 37793359)
1. Genotypic and Phenotypic Characteristics of Co-Trimoxazole-Induced Cutaneous Adverse Reactions.
Iamsumang W; Chanprapaph K; Sukasem C; Satapornpong P; Thadanipon K; Suchonwanit P; Jantararoungtong T; Anuntrangsee T
Dermatology; 2023; 239(6):966-975. PubMed ID: 37793359
[TBL] [Abstract][Full Text] [Related]
2. Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population.
Mortazavi H; Rostami A; Firooz A; Esmaili N; Ghiasi M; Lajevardi V; Amirzargar AA; Sheykhi I; Khamesipour A; Akhdar M
Dermatol Ther; 2022 May; 35(5):e15393. PubMed ID: 35187767
[TBL] [Abstract][Full Text] [Related]
3. Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions.
Nakkam N; Saksit N; Konyoung P; Amornpinyo W; Khunarkornsiri U; Purimart D; Pattanacheewapull O; Naewla T; Wattanachai P; Khaeso K; Chumworathayi P; Tassaneeyakul W
Drug Metab Pharmacokinet; 2022 Dec; 47():100480. PubMed ID: 36379177
[TBL] [Abstract][Full Text] [Related]
4. Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes.
Sukasem C; Pratoomwun J; Satapornpong P; Klaewsongkram J; Rerkpattanapipat T; Rerknimitr P; Lertpichitkul P; Puangpetch A; Nakkam N; Konyoung P; Khunarkornsiri U; Disphanurat W; Srisuttiyakorn C; Pattanacheewapull O; Kanjanawart S; Kongpan T; Chumworathayi P; Saksit N; Bruminhent J; Tassaneeyakul W; Chantratita W; Pirmohamed M
Clin Pharmacol Ther; 2020 Nov; 108(5):1078-1089. PubMed ID: 32452529
[TBL] [Abstract][Full Text] [Related]
5. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions.
Kongpan T; Mahasirimongkol S; Konyoung P; Kanjanawart S; Chumworathayi P; Wichukchinda N; Kidkeukarun R; Preechakul S; Khunarkornsiri U; Bamrungram W; Supharatwattanakun B; Mootsikapun P; Kwangsukstid S; Denjanta S; Vannaprasaht S; Rungapiromnan W; Suwankesawong W; Tassaneeyakul W; Tassaneeyakul W
Pharmacogenet Genomics; 2015 Aug; 25(8):402-11. PubMed ID: 26086150
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
7. Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients.
Sukasem C; Chaichan C; Nakkrut T; Satapornpong P; Jaruthamsophon K; Jantararoungtong T; Koomdee N; Sririttha S; Medhasi S; Oo-Puthinan S; Rerkpattanapipat T; Klaewsongkram J; Rerknimitr P; Tuchinda P; Chularojanamontri L; Tovanabutra N; Puangpetch A; Aekplakorn W
J Immunol Res; 2018; 2018():2780272. PubMed ID: 29546073
[TBL] [Abstract][Full Text] [Related]
8. Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians.
Wang CW; Tassaneeyakul W; Chen CB; Chen WT; Teng YC; Huang CY; Sukasem C; Lu CW; Lee YS; Choon SE; Nakkam N; Hui RC; Huang YH; Chang YC; Lin YY; Chang CJ; Chiu TM; Chantratita W; Konyoung P; Lee CN; Klaewsongkram J; Rerkpattanapipat T; Amornpinyo W; Saksit N; Rerknimitr P; Huang YH; Lin SH; Hsu CK; Chan CC; Lin YJ; Hung SI; Chung WH;
J Allergy Clin Immunol; 2021 Apr; 147(4):1402-1412. PubMed ID: 32791162
[TBL] [Abstract][Full Text] [Related]
9. HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption.
Moon J; Kim TJ; Lim JA; Sunwoo JS; Byun JI; Lee ST; Jung KH; Park KI; Jung KY; Jeon D; Yu KS; Jang IJ; Chu K; Lee SK
Epilepsia; 2016 Nov; 57(11):1879-1886. PubMed ID: 27666425
[TBL] [Abstract][Full Text] [Related]
10. HLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand.
Sukasem C; Jantararoungtong T; Kuntawong P; Puangpetch A; Koomdee N; Satapornpong P; Supapsophon P; Klaewsongkram J; Rerkpattanapipat T
Front Pharmacol; 2016; 7():186. PubMed ID: 27486401
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand.
Kategeaw W; Nakkam N; Kiertiburanakul S; Sukasem C; Tassaneeyakul W; Chaiyakunapruk N
J Med Econ; 2023; 26(1):1330-1341. PubMed ID: 37830976
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine.
Nakkam N; Konyoung P; Amornpinyo W; Saksit N; Tiamkao S; Khunarkornsiri U; Khaeso K; Pattanacheewapull O; Jorns TP; Chumworathayi P; Tassaneeyakul W
Br J Clin Pharmacol; 2022 Feb; 88(2):773-786. PubMed ID: 34350628
[TBL] [Abstract][Full Text] [Related]
13. HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.
Fricke-Galindo I; Martínez-Juárez IE; Monroy-Jaramillo N; Jung-Cook H; Falfán-Valencia R; Ortega-Vázquez A; Alonso-Vilatela ME; López-López M
Pharmacogenomics; 2014; 15(15):1881-91. PubMed ID: 25495410
[TBL] [Abstract][Full Text] [Related]
14. Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population.
Ihtisham K; Ramanujam B; Srivastava S; Mehra NK; Kaur G; Khanna N; Jain S; Kumar S; Kaul B; Samudrala R; Tripathi M
Seizure; 2019 Mar; 66():99-103. PubMed ID: 30826555
[TBL] [Abstract][Full Text] [Related]
15. HLA-associated antiepileptic drug-induced cutaneous adverse reactions.
Mullan KA; Anderson A; Illing PT; Kwan P; Purcell AW; Mifsud NA
HLA; 2019 Jun; 93(6):417-435. PubMed ID: 30895730
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis.
Sukasem C; Sririttha S; Chaichan C; Nakkrut T; Satapornpong P; Jaruthamsophon K; Jantararoungtong T; Koomdee N; Medhasi S; Oo-Puthinan S; Rerkpattanapipat T; Klaewsongkram J; Rerknimitr P; Tuchinda P; Chularojanamontri L; Tovanabutra N; Suvannang N; Rungrotmongkol T; Saokaew S; Aekplakorn W; Puangpetch A
Pharmacogenomics J; 2021 Dec; 21(6):682-690. PubMed ID: 34175889
[TBL] [Abstract][Full Text] [Related]
17. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population.
Ramírez E; Bellón T; Tong HY; Borobia AM; de Abajo FJ; Lerma V; Moreno Hidalgo MA; Castañer JL; Cabañas R; Fiandor A; González-Ramos J; Herranz P; Cachafeiro L; González-Herrada C; González O; Aramburu JA; Laosa O; Hernández R; Carcas AJ; Frías J
Pharmacol Res; 2017 Jan; 115():168-178. PubMed ID: 27888155
[TBL] [Abstract][Full Text] [Related]
18. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.
Chen CB; Hsiao YH; Wu T; Hsih MS; Tassaneeyakul W; Jorns TP; Sukasem C; Hsu CN; Su SC; Chang WC; Hui RC; Chu CY; Chen YJ; Wu CY; Hsu CK; Chiu TM; Sun PL; Lee HE; Yang CY; Kao PH; Yang CH; Ho HC; Lin JY; Chang YC; Chen MJ; Lu CW; Ng CY; Kuo KL; Lin CY; Yang CS; Chen DP; Chang PY; Wu TL; Lin YJ; Weng YC; Kuo TT; Hung SI; Chung WH;
Neurology; 2017 Jan; 88(1):78-86. PubMed ID: 27913699
[TBL] [Abstract][Full Text] [Related]
19. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population.
Gonçalo M; Coutinho I; Teixeira V; Gameiro AR; Brites MM; Nunes R; Martinho A
Br J Dermatol; 2013 Sep; 169(3):660-5. PubMed ID: 23600531
[TBL] [Abstract][Full Text] [Related]
20. Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population.
An DM; Wu XT; Hu FY; Yan B; Stefan H; Zhou D
Epilepsy Res; 2010 Dec; 92(2-3):226-30. PubMed ID: 21071176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
